Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
24
2
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(33 citation statements)
references
References 16 publications
4
24
2
3
Order By: Relevance
“…A few studies have reported mild-to-moderate reduction in lipase output. 16,39 We identified 17 studies 58,1316,4755 (Supplementary Table 4, http://links.lww.com/MPA/A487) where prevalence of decreased FE1 levels (cutoff of <200 μg/g and/or <100 μg/g) measured by monoclonal antibody (Schebo Biotech, Giessen, Germany) was reported. Collectively, these studies have included 940 non-DM controls and 3662 subjects with DM, of which 1724 had type 1 DM.…”
Section: Resultsmentioning
confidence: 99%
“…A few studies have reported mild-to-moderate reduction in lipase output. 16,39 We identified 17 studies 58,1316,4755 (Supplementary Table 4, http://links.lww.com/MPA/A487) where prevalence of decreased FE1 levels (cutoff of <200 μg/g and/or <100 μg/g) measured by monoclonal antibody (Schebo Biotech, Giessen, Germany) was reported. Collectively, these studies have included 940 non-DM controls and 3662 subjects with DM, of which 1724 had type 1 DM.…”
Section: Resultsmentioning
confidence: 99%
“…A smaller study in 150 participants with diabetes reported a 5.4% prevalence of type 3c diabetes. 8 Until additional studies are completed, it is reasonable to assume that the true prevalence of type 3c diabetes probably ranges from 1% to 9% of patients with diabetes, and 4–5% might be a reasonable working estimate.…”
Section: Estimated Prevalencementioning
confidence: 99%
“…However, most of these studies did not exclude cases with previous pancreatic disease, thus leading to a possible bias. In two recent studies, the prevalence of PEI in DM was less frequent than in previous studies, probably because pancreatic (type 3c, according to the new classification of American Diabetes Association: type 4 [33]) diabetes was excluded [28,29]. Low FE-1 was measured in only 5.4% of 150 consecutive type 1 and 2 diabetic patients after excluding patients with excessive alcohol consumption, medical history of abdominal surgery, other known reasons for malabsorption, previous pancreatic disease and DM lasting <5 years [28].…”
Section: Prevalence Of Exocrine Pancreatic Insufficiency In Diabetes mentioning
confidence: 99%
“…In two recent studies, the prevalence of PEI in DM was less frequent than in previous studies, probably because pancreatic (type 3c, according to the new classification of American Diabetes Association: type 4 [33]) diabetes was excluded [28,29]. Low FE-1 was measured in only 5.4% of 150 consecutive type 1 and 2 diabetic patients after excluding patients with excessive alcohol consumption, medical history of abdominal surgery, other known reasons for malabsorption, previous pancreatic disease and DM lasting <5 years [28]. In another recent study, PEI was diagnosed with FE-1 measurement in 16.8% of type 2 diabetic patients after excluding patients with an abnormal pancreatic morphology [29].…”
Section: Prevalence Of Exocrine Pancreatic Insufficiency In Diabetes mentioning
confidence: 99%